We are live on ! Find out more
CLB icon

Core Laboratories

345 hedge funds and large institutions have $7.51B invested in Core Laboratories in 2013 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 109 increasing their positions, 132 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

281% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 16

22% more funds holding in top 10

Funds holding in top 10: 911 (+2)

18% more capital invested

Capital invested by funds: $6.37B → $7.51B (+$1.14B)

14% more funds holding

Funds holding: 302345 (+43)

4.27% more ownership

Funds ownership: 82.36%86.63% (+4.3%)

17% less repeat investments, than reductions

Existing positions increased: 109 | Existing positions reduced: 132

49% less call options, than puts

Call options by funds: $15.4M | Put options by funds: $30M

Holders
345
Holders Change
+43
Holders Change %
+14.24%
% of All Funds
10.01%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.32%
New
61
Increased
109
Reduced
132
Closed
16
Calls
$15.4M
Puts
$30M
Net Calls
-$14.6M
Net Calls Change
-$14.8M
Name Holding Trade Value Shares
Change
Change in
Stake
Brown Advisory
1
Brown Advisory
Maryland
$609M +$4.29M +23,071 +0.7%
CG
2
Carmignac Gestion
France
$599M -$44.7M -240,416 -7%
EARNEST Partners
3
EARNEST Partners
Georgia
$546M +$532M +2,858,802 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$522M +$23.1M +124,217 +5%
ClearBridge Investments
5
ClearBridge Investments
New York
$474M +$31.6M +169,900 +7%
BAMCO Inc
6
BAMCO Inc
New York
$333M -$970K -5,212 -0.3%
Macquarie Group
7
Macquarie Group
Australia
$290M -$44.6M -239,627 -14%
WI
8
WHV Investments
California
$230M -$26.4M -142,117 -11%
Jennison Associates
9
Jennison Associates
New York
$222M -$2.04M -10,964 -0.9%
VAM
10
Vontobel Asset Management
New York
$215M -$109M -586,594 -34%
Morgan Stanley
11
Morgan Stanley
New York
$192M +$29.4M +158,206 +19%
BIT
12
BlackRock Institutional Trust
California
$138M +$23.9M +128,394 +22%
CWAM
13
Columbia Wanger Asset Management
Illinois
$137M -$2.03M -10,886 -1%
JHIU
14
Janus Henderson Investors US
Colorado
$128M -$7.07M -37,988 -5%
Artisan Partners
15
Artisan Partners
Wisconsin
$115M -$64.8M -348,222 -37%
American Century Companies
16
American Century Companies
Missouri
$105M -$1.43M -7,660 -1%
WCM Investment Management
17
WCM Investment Management
California
$99.3M +$13.9M +74,770 +17%
CC
18
Capital Counsel
New York
$94.8M -$2.35M -12,604 -2%
Goldman Sachs
19
Goldman Sachs
New York
$89.5M -$12.5M -67,268 -13%
Norges Bank
20
Norges Bank
Norway
$77.3M -$3.13M -16,844 -4%
SO
21
STRS Ohio
Ohio
$74.2M -$18.8M -101,000 -21%
State Street
22
State Street
Massachusetts
$73.7M +$3.26M +17,493 +5%
DDC
23
DF Dent & Co
Maryland
$67.7M +$1.63M +8,732 +3%
AII
24
AGF Investments Inc
Ontario, Canada
$63.4M +$1M +5,400 +2%
CPIM
25
Columbia Partners Investment Management
Virginia
$62.2M -$11.3M -60,508 -16%

CLB Hedge Fund Activity: Q4 2013 in Review

345 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q4 2013, worth a combined $7.51B — up 18% from $6.37B a quarter earlier.

Buyers outnumbered sellers: 61 funds opened new CLB positions and 16 closed out — a net gain of 45 holders — while 109 added to existing stakes and 132 trimmed.

The largest buyer was EARNEST Partners, opening a new position worth an estimated $532M. The largest seller was Vontobel Asset Management, cutting an estimated $109M.

  • 345 institutional investors held Core Laboratories (CLB) as of Q4 2013, up from 302 in Q3 2013.
  • Funds reported $7.51B of Core Laboratories stock for Q4 2013, up 18% quarter-over-quarter.
  • 61 funds opened new Core Laboratories positions in Q4 2013 and 16 closed out, a net change of +45 holders.
  • The largest Core Laboratories buyer in Q4 2013 was EARNEST Partners, an estimated $532M added.
  • The largest Core Laboratories seller in Q4 2013 was Vontobel Asset Management, an estimated $109M sold.

Based on aggregated 13F filings for Q4 2013.